Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • ONS Congress
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Cancer Rehabilitation Serves a Critical Role in Patient Care
    Prehabilitation
    Cancer Rehabilitation Serves a Critical Role in Patient Care
    October 11, 2019
    Complexity Is the Cornerstone of BMT Nursing
    Oncology nursing roles
    Complexity Is the Cornerstone of BMT Nursing
    October 07, 2019
    What the Research Says About Drug Interactions and Medical Cannabis
    Oncology drug research
    What the Research Says About Drug Interactions and Medical Cannabis
    October 04, 2019
    Take These Healthy Steps to Come Back From an Unexpected Event
    Nurse self-care
    Take These Healthy Steps to Come Back From an Unexpected Event
    September 27, 2019
    Uplift Young Adult Patients by Sharing YA Resources
    Patient Support
    Uplift Young Adult Patients by Sharing Resources
    September 20, 2019
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    Oncology Drug Reference Sheet: Erdafitinib
    Treatments

    Oncology Drug Reference Sheet: Erdafitinib

    Erdafitinib (Balversa™) is the first targeted therapy that the U.S. Food and Drug Administration approved for treatment of metastatic bladder cancer. 

    September 24, 2019
    Oncology Drug Reference Sheet: Atezolizumab’s Indications for Breast and Lung Cancer
    Treatments

    Oncology Drug Reference Sheet: Atezolizumab’s Indications for Breast and Lung Cancer

    The U.S. Food and Drug Administration (FDA) first approved atezolizumab (Tecentriq®) in 2016, but it received additional approvals when used in combination treatments for locally advanced or metastatic triple negative breast cancer (TNBC) and small cell lung cancer (SCLC) in March 2019.

    July 23, 2019
    Practice These Five Self-Care Strategies in Less Than Five Minutes
    Nurse self-care

    Practice These Five Self-Care Strategies in Less Than Five Minutes

    Oncology nursing is a rewarding profession that offers nurses opportunities to build meaningful relationships with patients and families, manage complex patient situations, and provide compassionate care during a scary time in someone’s life. But what makes oncology nursing so special can also make nurses more vulnerable to occupational stress, which can lead to compassion fatigue or burnout.   

    May 25, 2019
    Oncology Drug Reference Sheet: Ribociclib
    Clinical practice

    Oncology Drug Reference Sheet: Ribociclib

    Ribociclib is a CDK 4/6 inhibitor first approved by the U.S. Food and Drug Administration in early 2017 for postmenopausal women with HR-positive, HER2-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine therapy, based on the MONALEESA trial results. 

    February 26, 2019
    Opioids Have Been a Healthcare Concern Since the 1980s
    Pain management

    Opioids Have Been a Healthcare Concern Since the 1980s, but Here’s How Nurses Can Help

    Although the opioid crisis was formally labeled a public health emergency in late 2017, excess drug abuse beyond prescription directions has been a public health concern for much longer—since the 1980s, in fact. At the November 2018 Center for Advancing Palliative Care Annual Seminar in Orlando, FL, speakers Lynn Hallarman and Mary McPherson presented a session on how the opioid crisis came to be and what our role as nurses is in changing culture and ultimately addressing it.

    January 22, 2019
    Reality-Based Leadership Helps Nurses Cut the Drama So They Can Problem Solve
    Nurse self-care

    Reality-Based Leadership Helps Nurses Cut the Drama So They Can Problem Solve

    Nurses spend an average of 2.5 hours per day on drama per staff person, according to Cy Wakeman, the opening keynote speaker at the 2018 American Nurses Credentialing Center’s Magnet Conference in Denver, CO, in October. That’s right, take 2.5 and multiply it by how many staff are working that day. 

    December 18, 2018
    How APRNs Can Support Patients During Oral Agent Treatment
    Advanced practice nursing (APN)

    How APRNs Can Support Patients During Oral Agent Treatment

    Oral agents offer many patient benefits, one of which is the freedom to take the medication at home, allowing them to keep their daily routine and gain additional time and independence they would have spent traveling to the clinic for treatment. However, with that freedom comes additional patient responsibilities, and preparation from advanced practice RNs (APRNs) is necessary to ensure patients can self-manage symptoms and adhere to administration regimens. Research shows that patients experience severe symptoms on oral agents that may cause them to miss as many as one-third of the prescribed doses. How can APRNs empower patients to adhere to the treatment plan and ensure safe symptom self-management at home? 

    August 16, 2018
    Erin Dickman MS, RN, OCN®
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2019 Oncology Nursing Society
    Back to Top ▲